← Back to Search

LuCa + Health Disparity module for Lung Cancer

N/A
Waitlist Available
Research Sponsored by Georgetown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months post-randomization
Awards & highlights
No Placebo-Only Group

Summary

This trial tests two online training programs for doctors to improve their knowledge and practices regarding lung cancer screening. It focuses on primary care providers at MedStar and aims to see if adding health disparities information makes a difference. The effectiveness is measured through surveys and medical record reviews.

Eligible Conditions
  • Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months post-randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months post-randomization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of providers with improved mean attitudes score
Number of providers with improved mean lung cancer screening knowledge score
Secondary study objectives
Rate of lung cancer screening referrals

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: LuCa + Health Disparity moduleExperimental Treatment1 Intervention
Participants will be asked to complete the Health Disparities module that is an interactive CME/CE online course which offers 0.5 continuing education credit hours. The will also be asked to complete the LuCa course.
Group II: LuCa only moduleActive Control1 Intervention
LuCa is a free interactive CME/CE online course entitled, "Lung Cancer and the Primary Care Provider". For the purpose of this study, participants will be asked to complete session 1 which offers 1.0 continuing education credit hours, including AMA PRA Category 1 credits, AANP, and AAFP Prescribed credits.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LuCa + Health Disparity module
2021
N/A
~80

Find a Location

Who is running the clinical trial?

Georgetown UniversityLead Sponsor
347 Previous Clinical Trials
137,039 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,906 Previous Clinical Trials
41,011,951 Total Patients Enrolled
~19 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top